Payden & Rygel’s Corteva CTVA Stock Holding History

Payden & Rygel’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-188,390	Closed	-$15.8M	–	133
2026 Q1	$15.8M	Buy	+188,390	New	+$14.2M	1.21%	29

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Payden & Rygel's CTVA Position: Q2 2026 in Review

Payden & Rygel sold out of Corteva (CTVA) in Q2 2026, closing a stake of 188,390 shares — an estimated $15.8M sold.

Payden & Rygel first reported a position in CTVA in Q1 2026 and held it in 1 quarter. The position peaked at $15.8M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

Payden & Rygel reported no remaining Corteva position as of Q2 2026 after selling out during the quarter.
Payden & Rygel sold 188,390 Corteva shares in Q2 2026, an estimated $15.8M.
Payden & Rygel first reported a position in Corteva in Q1 2026 and held it in 1 quarter.
Payden & Rygel's Corteva position peaked at $15.8M in Q1 2026.
1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Payden & Rygel's 13F filing for Q2 2026, filed 31 Jul 2026.